Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nanoformulation-based sequential combination cancer therapy.

Gayong Shim1, Mi-Gyeong Kim1, Dongyoon Kim1

  • 1College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, 1 Gwanak-ro, Gwanak-gu, Seoul 08826, Republic of Korea.

Advanced Drug Delivery Reviews
|April 17, 2017
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evolution of siRNA Therapeutics: From Mechanistic Foundations to Clinical Expansion.

Pharmaceutics·2026
Same author

Neutrophil-Like Mitochondria Enable Blood-Brain Barrier Transmigration and Neuroprotection.

ACS nano·2026
Same author

Metabolism-modulating nanoparticles for remodeling adipose-liver crosstalk to reverse liver fibrosis.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same author

Intestinal microenvironment-modulating nanomedicines for inflammatory bowel disease.

Journal of controlled release : official journal of the Controlled Release Society·2026
Same author

HITE: HIV Inspired Lipid Nanoparticle Platform for CAR T Cell Engineering.

Nano letters·2026
Same author

Liver-Detargeted Aromatic Bioreducible mRNA Lipid Nanoparticles Confer Lymph Node Tropism and Robust Antigen-Specific Immunity.

Journal of the American Chemical Society·2026
Same journal

Silicone oil in protein drug products and its implications for formulation stability.

Advanced drug delivery reviews·2026
Same journal

Targeted delivery of proteolysis-targeting chimeras (PROTAC) and molecular glue degraders (MGD).

Advanced drug delivery reviews·2026
Same journal

Lysosome-targeting degrader delivery system: from formulation design to biomedical applications.

Advanced drug delivery reviews·2026
Same journal

Anti-PEG antibodies in nanomedicine: Mechanisms, risks, and opportunities.

Advanced drug delivery reviews·2026
Same journal

Optimizing macrophage-targeted intracellular delivery systems for safe and effective immunotherapies.

Advanced drug delivery reviews·2026
Same journal

Light-controlled CRISPR-dCas9 epigenome editing: advanced drug-delivery strategies and oncology applications.

Advanced drug delivery reviews·2026
See all related articles

Sequential drug delivery using nanotechnology offers a promising solution to overcome coordination issues in traditional cancer combination therapies, enhancing treatment effectiveness.

Area of Science:

  • Oncology
  • Nanotechnology
  • Pharmacology

Background:

  • Traditional cancer combination therapies face limitations due to drug pharmacokinetic and action site coordination issues.
  • Sequential drug administration can address temporal and spatial needs, improving combination antitumor therapy outcomes.
  • Nanotechnology-based carriers offer potential for sequential drug delivery, targeting tumor cells and enhancing efficacy.

Purpose of the Study:

  • To review the application of nanotechnology-based multistage drug delivery systems for cancer treatment.
  • To highlight the enhancement of antitumor efficacy through sequential treatment and modulated dosing regimens.
  • To discuss the challenges and potential of nanotechnology in clinical cancer therapy.

Main Methods:

  • Review of existing literature on nanotechnology-based drug delivery for cancer.
Keywords:
Anticancer therapyCombinationNanoformulationSequential deliveryStimulus-triggered release

Related Experiment Videos

  • Analysis of single nanoformulations capable of sequential drug release.
  • Focus on strategies for modulating dosing regimens and enhancing drug distribution.

    • Main Results:

    • Sequential drug release from nanoformulations demonstrates synergistic anticancer activity.
    • Strategies include cascaded drug delivery and remodeling of the tumor microenvironment.
    • Nanotechnology enables targeted and sustained delivery, improving therapeutic outcomes.

    Conclusions:

    • Nanotechnology-based sequential drug delivery is a promising strategy for overcoming limitations in current cancer combination therapies.
    • Multistage drug delivery systems can enhance antitumor efficacy by optimizing drug regimens.
    • Further research and clinical translation are needed to fully realize the potential of these advanced therapeutic approaches.